Zimmer Biomet Holdings, Inc.

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana, USA. Originally named Zimmer Holdings, Inc., the company was renamed in 2015 following the acquisition of Biomet. It is a global leader in musculoskeletal healthcare, specializing in the design, manufacturing, and marketing of orthopedic reconstructive products, sports medicine solutions, biologics, extremities and trauma products, spine, craniomaxillofacial and thoracic devices, dental implants, and related surgical products. Its solutions are widely used for the treatment of disorders or injuries involving bones, joints, and supporting soft tissues.

Core Business & Key Technologies

The company operates through four divisions: Americas Orthopaedics, EMEA (Europe, Middle East & Africa), Asia Pacific, and Americas Spine & Global Dental. In 2024, it generated $6.7 billion in revenue, with R&D expenses reaching $620 million (9.2% of revenue). Its product portfolio includes knee solutions such as the Persona Knee, NexGen Knee Implants, and Vanguard Knee; hip systems like the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System; and S.E.T. products including the JuggerKnot Soft Anchor System and Gel-One Cross-linked Hyaluronate. Its advanced technologies focus on implant design, material innovation, biologics integration, and digital surgical solutions.

Market Position & Flagship Products

Zimmer Biomet’s products are sold in over 100 countries, with strong presence in the U.S., Europe, Asia Pacific, and Latin America. Its flagship Persona Knee, introduced in 2012, is a customizable knee replacement solution, while the NexGen Knee Implants, launched in 1998, remain among the most widely used systems in the U.S. The Vanguard Knee, launched in 2002, offers high personalization for patients. In hip replacements, the Taperloc Hip System (1999), Avenir Complete Hip System (2007), and Arcos Modular Hip System (1990) represent the company’s technological strength and clinical reliability. These products reinforce its leading role in musculoskeletal healthcare solutions worldwide.

Contact Information

• Address: 345 East Main Street, Warsaw, IN 46580, USA

• Phone: (800) 613-6131

• Email: zimmer.consumerrelations@zimmer.com
  

Stock Information

• New York Stock Exchange (NYSE): ZBH.N

• Vienna Stock Exchange (Wiener Börse): ZBH.VI